Constant Pharmaceuticals   Report issue

For profit Phase 1 Phase 2
Founded: Brookline MA United States (2007)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2008
NCT00757250
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Constant Therapeutics | Constant Therapeutics LLC